MoneyWorks4Me

Pfizer - Quaterly Results

09 Feb 2023 Evaluate
A decrease in the sales to Rs. 6217.50 millions was observed for the quarter ended December 2022. The sales stood at Rs. 6759.00 millions during the similar quarter previous year.A meek growth of 4.69% was reported for the quarter ended December 2022 to Rs. 1506.60  millions from Rs. 1439.10 millions.Operating profit for the quarter ended December 2022 rose to 2308.60 millions as compared to 2134.30 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 6217.50 6759.00 -8.01 18521.20 20613.30 -10.15 26109.90 22385.50 16.64
Other Income 274.10 182.60 50.11 696.70 455.30 53.02 626.50 811.20 -22.77
PBIDT 2308.60 2134.30 8.17 6966.60 7158.10 -2.68 8983.80 7932.40 13.25
Interest 38.40 21.80 76.15 108.60 66.40 63.55 104.90 151.10 -30.58
PBDT 2270.20 2112.50 7.47 7383.90 7091.70 4.12 8878.90 7781.30 14.11
Depreciation 263.40 271.60 -3.02 791.00 813.90 -2.81 1150.00 1094.10 5.11
PBT 2006.80 1840.90 9.01 6592.90 6277.80 5.02 7728.90 6687.20 15.58
TAX 500.20 401.80 24.49 1650.10 1410.10 17.02 1603.30 1711.10 -6.30
Deferred Tax -17.80 -146.70 -87.87 -203.80 -263.90 -22.77 -359.30 -125.20 186.98
PAT 1506.60 1439.10 4.69 4942.80 4867.70 1.54 6125.60 4976.10 23.10
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 37.13 31.58 17.59 37.61 34.73 8.32 34.41 35.44 -2.90
Peers
Company Name CMP
Sun Pharma. Inds. 1850.80
Dr. Reddys Labs. 1216.60
Cipla 1382.10
Lupin 2101.00
Zydus Lifesciences 1171.95
View more..